SAN DIEGO, May 19, 2025 /PRNewswire/ — At the CLEANPOWER 2025 conference in Phoenix this week, SOLV Energy announced several awards from leading developers to construct more than 6 gigawatts (GW) of utility-scale solar and storage projects. The projects are in multiple states, including Arizona, Mississippi, Nevada, Oregon, Texas and California and include assets owned by longstanding customers such as Arevon, Clēnera and Sol Systems, as well as new customers such as NewSun Energy, Enfinity Global and Panamint Capital. Construction mobilizations for the new projects are scheduled to begin in 2025 and beyond.

To support the growing demand for power across the United States, SOLV Energy is making significant investments in hiring and training regional project teams, including recruiting local project managers with insights into regional conditions, permitting processes and regulatory requirements. SOLV Energy is also expanding the scope of its self-perform capabilities to accelerate construction timelines, increase quality and reduce costs for the company’s customers. In January, the company announced the acquisition of SDI Services, LLC (fka Sacramento Drilling), a provider of foundation solutions for solar energy and T&D projects. The acquisition brings solar predrill and pile foundation capabilities in-house, enabling SOLV Energy to support complex projects in diverse terrain and environmental conditions.

“Demand for energy is continuing to grow rapidly and we are committed to investing in the capabilities our customers need for larger and increasingly complex power projects,” said George Hershman, CEO of SOLV Energy. “The significant number of projects that we have been awarded so far this year shows that customers recognize the investments we have made to expand our capabilities, and our value as a true lifecycle provider.”

About SOLV Energy
SOLV Energy is a leading provider of infrastructure services to the power industry, delivering integrated solutions across the full project lifecycle, from design through long-term operation. Since 2008, we have built more than 500 utility-scale solar and storage plants and related T&D infrastructure, totaling 20 GW of generating capacity. SOLV Energy also provides operations and maintenance (O&M) services to 143 operating power plants, representing over 17 GW of generating capacity across more than 30 states. We remain long-term partners by offering value-added services including SCADA solutions, large-scale repair, emergency response and repowering services to maximize project performance and energy availability. To learn more, visit solvenergy.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/solv-energy-announces-more-than-6-gws-of-new-project-awards-across-the-us-302458543.html

SOURCE SOLV Energy

  • Pepsi’s global ambassadors Alexia Putellas, Lauren James, Leah Williamson, Caroline Graham Hansen and Farah Jefry star in latest film, Refresh the Game.
  • Women’s football superstars take fans on a journey through time as they refresh some of Pepsi’s most iconic footballing moments.
  • Football legends David Beckham, Pelé, and Ronaldinho join the action, as the film unites players across generations, clubs and countries through the love of the game.
  • Refresh the Game celebrates the unapologetic challenger spirit, talent and personalities of football, ensuring the next 50 years of the game are just as legendary as the last.

LONDON, May 19, 2025 /PRNewswire/ — Pepsi® has brought together football legends from across generations, clubs and countries in a new star-studded, global campaign. Refresh the Game features today’s icons of football united with legends of the past, as they refresh Pepsi’s most memorable footballing moments over the past 50 years.

For half a century, Pepsi has been at the heart of football culture, delivering era-defining films that shine a light on the sport’s most legendary figures. From Pelé’s debut in the 1970s to David Beckham’s wild west standoff and Ronaldinho’s beachside brilliance. Refresh the Game is no different – it’s a celebration of footballing icons and the stars redefining the game today.

With record-breaking viewership and surging participation, women’s football is entering a new era in becoming the fastest growing sport on the planet, and Pepsi is committed to strengthening its future.

Its lineup of worldclass talent, including Alexia Putellas, Lauren James, Caroline Graham Hansen, Farah Jefry and Leah Williamson, are rewriting the rules and shattering stereotypes. Euro-conquering heroes, Champions League legends, prolific scorers, Ballon d’Or Feminin and Women’s Super League royalty, this all-star lineup are defining dominance. On and off the pitch, their jaw-dropping skills, dynamic personalities, and unapologetic flair are changing the game.

Refresh the Game opens with Putellas, James, Graham Hansen and Jefry in a press conference before they are transported to famous scenes of the past. First up, Putellas joins Pelé on the pitch with scenes from the 1974 film Join the Pepsi Generation. Pelé and Putellas unite— he delivers a precision pass, and she, with effortless brilliance, rainbow flicks the ball over the defender.

Alexia Putellas, commented: “To be ‘playing’ with the legendary Pelé, even in a fictional game, is an opportunity I never thought possible. Growing up, Pelé was an icon on and off the pitch – and his legacy continues today. I hope this film helps ignite that kind of motivation in young athletes everywhere, showing them there is a place in football for everyone.”

Pele Foundation commented: “To see Pelé as a part of a campaign focused on inspiring the younger generation aligns with our efforts as a charity to empower children around the world. The film highlights the importance of lifting up other athletes and inspiring them to reach their potential. We’re glad that Pelé’s legacy continues to live on.

In an ode to Pepsi’s 2005 Surfers film the audience is transported into the iconic scene, where footballing legends Ronaldinho and Caroline Graham Hansen defy gravity effortlessly exchanging passes across the waves. Moments later, Leah Williamson arrives on the beach, delivering an epic volley toward the legendary Pepsi cooler just as Alexia Putellas grabs a refreshing can of Pepsi, before the film concludes with the ambassadors back in the present day.

Caroline Graham Hansen commented: “I remember so clearly watching the original Surfers film on TV when I was younger, so being part of this campaign and refreshing that scene felt quite surreal. The beach battle scene was so much fun, and working with fellow athletes brought out an extra level of energy in me.”

Ronaldinho commented: “Seeing the Surfers scene brought to life again has been so nostalgic and Graham Hansen steals the show. The film’s message of inspiring young athletes is profoundly important to me. It demonstrates that ambitious dreams, coupled with unwavering effort, can lead to extraordinary achievements.”

Leah Williamson commented: “I am so proud to be part of Pepsi’s Refresh the Game campaign and to stand alongside legends of the game. It’s a privilege to be part of something that unites generations and inspires the next wave of footballers around the world.”

The film cuts to David Beckham, standing in a wild west saloon, a reprise from 2003’s Wild West. James intercepts an ice-cold bottle of Pepsi as it slides across the counter before it reaches the former England international. James then joins Jefry outside for a cheeky nutmeg before grabbing a can of Pepsi.

Lauren James commented: “Sharing the screen with legendary players of the past and future is a dream come true. As a lifelong fan, getting the chance to appear in a Pepsi campaign alongside players that are redefining today’s game will go down as a career highlight for me.”

David Beckham added: “We’re witnessing a new generation of sporting superstars, and it’s been an honour to feature alongside them. The players in this campaign have played a pivotal role in getting women’s football to where it is today.”

Farah Jefry commented: “Everyone grew up watching Pepsi’s iconic football ads and to be starring in one of them myself has been an unbelievable experience. I never expected to be battling it out in the Wild West with my fellow footballer Lauren James!”

Cathy Graham Kidd, Senior Marketing Director at Pepsi, commented: “Our new film Refresh the Game celebrates football legends of the past and champions the stars redefining the game today. At Pepsi we are committed to accelerating women’s football, supporting those who challenge conventions to drive excitement and change. By using the power of entertainment, together, we want to bring women’s football to new audiences by showcasing the raw talent and joy it brings. 

“Pepsi has always been about refreshing and reinventing the status quo – whether it’s through our products or partnerships – and this campaign is a celebration of that. We have an unmissable summer of football ahead of us and we can’t wait to watch it with the rest of the world.”

Pepsi is championing the icons of the game around the world – from globally renowned talent to local rising stars, including; Signe Bruun and Josefine Hasbo (Denmark), Nadine Riesen and Riola Xhemaili (Switzerland), Jéssica Silva and Tatiana Pinto (Portugal), Stina Blackstenius (Sweden) and Johanna Rytting Kaneryd (Sweden) – who will make special cameo appearance in Refresh the Game across screens in market.

Fuelling the ascension and future of football, Pepsi has renewed its commitment to support UEFA Women’s Football to 2030 – marking a groundbreaking, long-term pledge to drive the sport’s continued growth. This industry-first investment reflects Pepsi’s confidence in the future of the women’s game and its dedication to elevating its players to new heights.   

Refresh the Game celebrates the iconic personalities of football, whilst ensuring the next 50 years are just as legendary as the last. Pepsi fans worldwide can follow Pepsi channels to see the film and more from the players as the campaign unfolds: X (Twitter), Instagram, Facebook.

Notes to Editors

About PepsiCo 

PepsiCo products are enjoyed by consumers more than one billion times a day in more than 200 countries and territories around the world. PepsiCo generated nearly $92 billion in net revenue in 2024, driven by a complementary beverage and convenient foods portfolio that includes Lay’s, Doritos, Cheetos, Gatorade, Pepsi-Cola, Mountain Dew, Quaker, and SodaStream. PepsiCo’s product portfolio includes a wide range of enjoyable foods and beverages, including many iconic brands that generate more than $1 billion each in estimated annual retail sales.

Guiding PepsiCo is our vision to Be the Global Leader in Beverages and Convenient Foods by Winning with pep+ (PepsiCo Positive). pep+ is our strategic end-to-end transformation that puts sustainability and human capital at the center of how we will create value and growth by operating within planetary boundaries and inspiring positive change for planet and people. For more information, visit www.pepsico.com, and follow on X (Twitter), Instagram, Facebook, and LinkedIn @PepsiCo.

Video – https://mma.prnewswire.com/media/2689700/PepsiCo_1.mp4
Photo – https://mma.prnewswire.com/media/2689625/PepsiCo_2.jpg
Photo – https://mma.prnewswire.com/media/2689627/PepsiCo_3.jpg
Photo – https://mma.prnewswire.com/media/2689628/PepsiCo_4.jpg
Logo – https://mma.prnewswire.com/media/2665176/Pepsi_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/refresh-the-game-pepsi-unites-football-legends-across-generations-in-latest-global-campaign-302457996.html

SOURCE PepsiCo

TAIPEI, May 19, 2025 /PRNewswire/ — The Open Compute Project Foundation (OCP) is redesigning data center power architecture to support AI’s growing demands, introducing “1 Megawatt racks” that could slash energy losses from 40% to just 7%, according to Chief Innovation Officer Cliff Grossner.

With AI infrastructure stretching the limits of current systems, OCP’s community of over 400 corporate members is developing open standards to address critical bottlenecks in compute density, power distribution, and cooling.

“The industry is at an inflection point,” said Grossner. “We no longer assume that all processors can be generic. We need to create custom processors for specific workloads.”

Power Revolution

Current power conversion processes waste approximately 40% of energy when converting from high voltage to chip-level voltage—a significansust inefficiency as facilities increasingly consume hundreds of megawatts.

OCP’s proposed “1 Megawatt racks” would move power supplies out of server racks into separate units. Eventually, power generation could move entirely outside computing floors, with facilities re-architected to supply 400 or 800 volt DC power.

Future data centers may incorporate on-site renewable energy generation through solar, wind, and potentially small nuclear reactors as part of an ecosystem approach to power management.

Environmental Focus

With data centers projected to consume 3% of global electricity by 2030, sustainability has become a priority. OCP is developing metrics beyond traditional Power Usage Effectiveness (PUE) to address water consumption and equipment efficiency.

“A data center is not a standalone object in the future,” Grossner noted. “It’s going to be part of an ecosystem that includes potentially a wind farm next to it, and proximity to buildings that can use the heat produced.”

The organization is also investigating alternative concrete formulations to reduce carbon emissions in construction and collaborating with Infrastructure Masons on standardized carbon accounting for IT equipment.

Cooling Transformation

Increasing computational density is forcing a transition from air to liquid cooling systems.

“The thermal management needs of current and next-generation silicon make it pretty clear that chips will be cooled either by single or two-phase liquid cooling,” Grossner said.

OCP is working to standardize liquid cooling delivery systems, including specifications for connectors, pressures, and fluid properties to ensure interoperability across vendors.

Silicon Innovation

OCP has established a marketplace with over 25 suppliers offering modular semiconductor components, positioning itself as the “front door to the open chiplet economy.” This approach enables specialized silicon components to be combined for optimal performance.

The organization envisions distinct roles in this ecosystem: companies creating chiplets, businesses building ASICs, and firms providing support through design tools and testing services.

Education Initiatives

OCP recently launched the OCP Academy to support adoption of its standards and provides access to hundreds of OCP-recognized products through its marketplace. OCP aims to remain the premier organization for AI infrastructure by standardizing silicon, power, cooling, and interconnects; supporting complete system development; and providing industry education.

As AI continues to redefine computing requirements, OCP’s role in fostering open, sustainable, and scalable infrastructure appears increasingly vital to managing the environmental impact of explosive computational growth.

Global Expansion

With 30% of its membership in Asia-Pacific (primarily Taiwan), OCP will hold its APAC Summit in Taipei on August 5-6, 2025. “Taiwan’s semiconductor industry is a key partner,” Grossner emphasized.

Event Link: https://www.opencompute.org/summit/2025-ocp-apac-summit

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/digitimes-asia-ocp-targets-1mw-racks-to-cut-data-center-energy-losses-to-7-302458824.html

SOURCE DIGITIMES ASIA

FORNEBU, Norway, May 19, 2025 /PRNewswire/ — Reference is made to the announcement made by Aker Horizons ASA (the “Company” or “Aker Horizons”) on 12 May 2025 regarding the Company’s launch of a buy-back offer for the Convertible Bond 2021/2026 with ISIN NO0010921596 (the bonds issued thereunder, the “Convertible Bonds“).

No bonds were bought back in the buy-back offer, and NOK 1.6 billion of Convertible Bonds remain outstanding, of which NOK 1.3 billion are held by Aker Capital AS.

DNB Carnegie, a part of DNB Bank ASA, acted as Manager to the Company for the buy-back offer.   

Contact:

Jonas Gamre, Investor Relations
Tel: +47 97 11 82 92
Email: jonas.gamre@akerhorizons.com 

IMPORTANT INFORMATION

This communication is not an offer to sell or purchase any securities, or the solicitation of an offer to sell or purchase any securities in any jurisdiction in which, or to any person to whom, such solicitation is not authorized or would be unlawful. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

The publication, distribution or release of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/aker-horizons/r/aker-horizons-asa—result-of-buy-back-offer-for-convertible-bonds,c4151941

Cision View original content:https://www.prnewswire.com/news-releases/aker-horizons-asa–result-of-buy-back-offer-for-convertible-bonds-302458724.html

SOURCE Aker Horizons

RAYONG, Thailand, May 18, 2025 /PRNewswire/ — ChangAn Automobile (“ChangAn” or “the Company”), an intelligent low-carbon mobility technology company, has accelerated its Vast Ocean Plan for global expansion with the launch of production at its first international new energy vehicle (NEV) production base in Rayong, Thailand. The facility marks a transition from product exports to exporting entire industrial ecosystems. The Rayong factory incorporates manufacturing systems, R&D processes, and supply chain standards, establishing a green, intelligent, and replicable model for sustainable global operations.

Coinciding with the launch of the Rayong factory, ChangAn also celebrated the rollout of its 28.59 millionth vehicle, a right-hand drive DEEPAL S05 tailored for global markets. This milestone underscores ChangAn’s commitment to its Vast Ocean Plan, which aims to elevate five major overseas markets—Southeast Asia, the Middle East and Africa, Central and South America, Europe, and Eurasia—to the same strategic level as its home market in China. By scaling globally with smart manufacturing and localised collaboration, ChangAn is accelerating its transformation into a world-class automobile brand.

The Rayong factory spans approximately 245 rai (392,000 square meters), and boasts five workshops, including welding, painting, general assembly, engine assembly, and battery, plus auxiliary functions such as exterior inspection. As a green, energy-efficient facility, it features streamlined operations with daylight optimisation, photovoltaic systems, and greywater/rainwater recycling, reducing per-vehicle energy consumption by around 20%. Automated processes, adaptive conveyance systems, and advanced assembly and testing ensure production efficiency and product quality for diverse market demands. In the future, the CHANG-AN, DEEPAL, and AVATR brands will be produced at the Rayong Factory, with annual capacity expected to double from 100,000 to 200,000 units by 2027.

ChangAn’s Vast Ocean Plan reflects global industry trends, with the Rayong Factory marking a major step in its international operation. To date, ChangAn has held brand launches in Mexico, Saudi Arabia, and Germany. In particular, since launching its Southeast Asia brand initiative in Thailand in November 2023, the company has introduced seven new models to the Thai market including the DEEPAL S07, E07, and AVATR 11, with cumulative sales exceeding 14,000 units, ranking among the top four in Thailand’s NEV market.

ChangAn’s Rayong factory marks the culmination of 41 years of automotive manufacturing expertise. Blending this legacy with local operations, the facility has established a global system standard cultivating international talent. It sets the foundation for replicating ChangAn’s global factory standards and serves as a best-practice model for international operations, reflected in four key areas, namely, the application of ChangAn’s CPS lean manufacturing system, emphasising leadership, productivity, and performance. The integration of seven operational systems and six core processes forms the core of the Company’s lean management strategy, reflecting its commitment to excellence. Leveraging the CAPDS system, the plant strengthens Southeast Asian technical support and engineering development. It focuses on new energy, intelligent systems, adaptive design, and advancing regional product innovation. Built on the CA-PLS framework, Rayong is ChangAn’s first international site to standardise production management enabling rapid product launches. The plant marks an innovative, resilient, dual-circulation supply chain linking China and Thailand.

“This is a big moment for ChangAn – a giant leap from exporting cars to building local ecosystem,” said Zhu Huarong, Chairman of ChangAn Automobile. “Despite the huge challenges brought by anti-globalization, ChangAn stays committed to Vast Ocean Plan. With a spirit of win-win cooperation, we will contribute more to economic and social development of Thailand, and drive the global auto industry forward.”

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/changan-opens-first-international-nev-manufacturing-base-in-thailand-expanding-its-industry-export-model-302458660.html

SOURCE ChangAn Automobile

  • Food loss and waste account for 8-10% of annual global greenhouse gas emissions, according to the UNFCCC 
  • Namboozo and Muyita’s sachets keep fruit fresh by up to extra 30 days, reducing waste and boosting farmer incomes
  • The pair are among top ten innovators for the Young Inventors Prize, awarded by the European Patent Office (EPO) on 18 June 2025

MUNICH, May 18, 2025 /PRNewswire/ — Over 1 billion tonnes of food are wasted annually, while 783 million people face hunger, according to the United Nations Framework Convention on Climate Change (UNFCCC). Ugandan entrepreneurs Sandra Namboozo (26) and Samuel Muyita (27), founders of Karpolax, have developed a plant-based sachet that extends the shelf life of fresh fruit by up to 30 days. Their sustainable, biodegradable preservation solution has earned them a place in top 10 innovators in the Young Inventors Prize 2025, known as Tomorrow Shapers, which recognises young inventors tackling global challenges. They were selected from 450 candidates by an independent jury.

Sustainable preservation and fresher produce

Despite the steady increase in the global population, around 40% of all food produced does not reach the market, according to the World Wildlife Fund.

Namboozo and Muyita both grew up in farming families and saw first-hand the challenges of post-harvest losses, which have a devastating impact on the profit of small-scale farmers. Determined to find a natural and more affordable alternative to synthetic preservers, they developed sachets, which release a blend of plant-derived volatile organic compounds (VOCs) to slow ripening and prevent spoilage. The compounds – extracted from cloves, lemongrass, eucalyptus and wintergreen – inhibit ethylene production, the natural gas responsible for fruit ripening, and offer protection against mould, fungi and bacteria. Their solution allows for the controlled, sustained release of these compounds, tailored to different fruit types, thereby providing a biodegradable alternative to conventional artificial preservers.

Pilot tests conducted with Uganda’s National Agricultural Research Organization showed that mangoes stored with the sachets remained fresh for 33 days, while those without them lasted only 11 days. The sachets have since been successfully used on bananas, apples, and oranges. With an affordable price point, Karpolax’s sachets are particularly suited to smallholder farmers and local markets, offering a cost-effective and locally accessible way to reduce food waste and increase earnings.

Protecting innovation for lasting impact

“Farmers are one of our biggest customer groups. We wanted to use our knowledge and technical skills to develop something that would not just end on a paper in a lab but really be used by somebody,” explains Namboozo.

The duo met while studying at Makerere University in Kampala, where they quickly bonded over a shared ambition to reduce food waste. They launched Karpolax in 2020 and aim to expand its reach across Africa, targeting Kenya, Rwanda and beyond. “Starting from zero, you need to source for that funding yourself. We had some supervisors from the university who supported us and made us feel confident that we could succeed,” added Muyita.  

By 2023, Karpolax had already worked with over 100 farmers, 20 exporters and 250 market vendors. The company is now expanding its product line to include sachets for pineapples, capsicum and berries. 

The Young Inventors Prize celebrates worldwide innovators 30 and under using technology to address global challenges posed by the United Nations Sustainable Development Goals (SDGs). Namboozo and Muyita’s work supports SDG 2 (Zero Hunger) by reducing post-harvest losses and SDG 12 (Responsible Consumption and Production) by promoting sustainable food preservation practices.

The prizes of the 2025 edition will be announced during a ceremony livestreamed from Iceland on 18 June 2025. 

Find more information about the invention’s impact, the technology and the inventor’s story here.

About the Young Inventors Prize

Aimed at individuals 30 and under, the Young Inventors Prize showcases the transformative power of youth-driven solutions and recognises the remarkable young people paving the way to a more sustainable future. Established in 2022, trophies were first handed out during the European Inventor Award ceremony. From 2025 onwards, the Prize will move up a gear with its own dedicated event, held separately from the Award. Among the 10 Tomorrow Shapers selected for each edition, three will be awarded a special prize: World Builders, Community Healers, and Nature Guardians. In addition, a People’s Choice winner, voted by the public online, will be revealed. Each Tomorrow Shaper will receive EUR 5 000, the three special prize winners will each receive an extra EUR 15 000. The People’s Choice winner will be awarded an additional EUR 5 000. Read more on the Young Inventors Prize eligibility and selection criteria.

About the EPO

With 6,300 staff members, the European Patent Office (EPO) is one of the largest public service institutions in Europe. Headquartered in Munich with offices in Berlin, Brussels, The Hague and Vienna, the EPO was founded with the aim of strengthening co-operation on patents in Europe. Through the EPO’s centralised patent granting procedure, inventors are able to obtain high-quality patent protection in up to 46 countries, covering a market of some 700 million people. The EPO is also the world’s leading authority in patent information and patent searching.

Cision View original content:https://www.prnewswire.com/news-releases/extending-the-shelf-life-of-fruit-ugandan-entrepreneurs-sandra-namboozo-and-samuel-muyita-in-top-10-innovators-of-the-young-inventors-prize-2025-awarded-by-the-european-patent-office-epo-302458082.html

SOURCE European Patent Office (EPO)

SAN FRANCISCO and SUZHOU, China, May 18, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces the release of its “2024 Environmental, Social and Governance (ESG) Report”, highlighting the Company’s strategies, actions, and achievements in sustainable development across five pillars, which include “Excellent Governance”, “Enjoying Good Health”, “High Quality as Key”, “People First” and “Embracing Ecology”.

Dr. Michael Yu, Founder, Chairman and CEO of Innovent, stated: “As China’s leading biopharmaceutical company, Innovent consistently navigates the pulse of the times with strategic foresight, forging a closed-loop system for value creation through synergistic integration of global innovation-driven strategies and sustainable development practices. We achieved an MSCI ESG rating of AAA, as the only biotech in China and one of just three globally to receive this rating.

Throughout the year of 2024, we remained committed to our mission, ‘to empower patients worldwide with affordable, high-quality biopharmaceuticals,’ and stayed true to our original aspiration, ‘Start with Integrity, Succeed through Action.’ We deeply integrated social responsibility into our business practices, actively responded to the United Nations Sustainable Development Goals (SDGs), strengthened our governance structure, improved operational efficiency, advanced high-quality innovation, promoted diversity and empowerment among employees, and strived for low-carbon development. These initiatives firmly honored our commitment to sustainable growth. We have embedded ESG principles into the fabric of our organization, which enables us to continuously create multidimensional value for shareholders, employees, patients, and society.”

Building Enduring Excellence through Lean Governance

Robust governance is the cornerstone of sustainable business development. In 2024, Innovent further refined its ESG governance framework to ensure agility in responding to global changes while maintaining steady, compliant operations.

We strengthened compliance management through continuous improvement of risk management systems and the upholding of rigorous business ethics standards. Looking ahead, we are committed to building a stable and sustainable business ecosystem in collaboration with our partners.

  • Board Diversity: added one female Executive Director, with every Board Committee now including at least one female chair or member.
  • Compliance, anti-corruption, and business ethics training: 100% participation among Directors and employees.
  • Supplier business ethics: 100% of suppliers signed the “Commitment to Compliance”.
  • Official ESG website: launched in 2024, underscoring the company’s firm commitment to sustainable development.
  • ESG recognition: achieved an MSCI ESG rating of AAA, the only biotech in China and one of just three globally to receive this rating.

MSCI ESG RATING

Driving Inclusive Healthcare through Innovation

Bridging geographic and economic gaps through innovative therapies remains Innovent’s unwavering goal. Guided by our company strategy, “To discover new medicines through innovation and deliver them through our global platforms”, Innovent has solidified its oncology leadership in China, achieved multiple groundbreaking advancements in chronic disease therapies, and expanded our global impact. Out dedication to scientific progress is grounded in a strong sense of social responsibility, which extends to improving drug accessibility and affordability for patients worldwide, rural education, volunteer activities, and broader community support initiatives.

  • Improving drug accessibility through an innovative pipeline: 15 commercialized products have benefited 5 million patients cumulatively.
  • 3 New Drug Applications under regulatory review, 4 assets in Phase III or pivotal clinical trials and 15 molecules in early clinical development. Oncology and general biomedicine have become the Company’s two growth engines.
  • 6 drugs or assets granted 13 orphan drug designations, with 2 drug candidates for rare diseases in preclinical and clinical stages.
  • SYCUME® (teprotumumab N01 injection) was launched as China’s first IGF-1R antibody for the treatment of thyroid eye disease, ending a 70-year absence of treatment options and transforming care for this rare condition.
  • Enhancing drug affordability by supporting medical insurance coverage with 6 medicines (TYVYT®, BYVASDA®, HALPRYZA®, SULINNO®, Olverembatinib, and SINTBILO®) included in China’s National Reimbursement Drug List (NRDL) and 8 medicines (Pemazyre®, Cyramza®, Retsevmo®, FUCASO®, TYVYT®, DOVBLERON®, Jaypirca® and DUPERT®) included in the Catalog of Specific Drug Reimbursements under Huimin Insurance Programs.
  • SINTBILO® became China’s first domestically developed PCSK9 inhibitor included in the NRDL.
  • Patient assistance programs have benefited over 200,000 patients, with donated medicines valued at more than RMB 3.6 Billion.
  • Health education and public welfare programs benefited over 240,000 patients.
  • Ongoing efforts in supporting rural education have cumulatively benefited nearly 4,000 teachers and students.
  • Innovent volunteer teams contributed a total of 2,754 hours of community service, reflecting our long-term commitment to social responsibility.

Delivering Life-Changing Quality

High-quality is a foundational principle at Innovent that underpins our mission to deliver safer, more effective therapies to patients. Patient-centricity drives our adherence to internationally recognized quality standards across the entire product lifecycle, from development and manufacturing to distribution. Even in the face of complex external environments, we actively collaborate with industry partners to elevate sector-wide benchmarks and maintain a resilient, sustainable dual-sourcing supply chain. Our responsible marketing practices further prioritize transparency and the protection of patient rights.

Innovent Biologics currently operates 140,000 L of total production capacity, comprising 60,000L of antibody production capacity at Suzhou manufacturing site and 80,000L of antibody and ADC production capacity at Hangzhou manufacturing site. With an additional 90,000L of capacity in plan at the Hangzhou site, the total production capacity will reach 230,000L upon full completion.

  • All commercially operational production facilities are 100% GMP-certified.
  • Reached 100% batch success rate in drug substance manufacturing.
  • Maintained 100% pass rate in audits conducted by regulatory authorities and strategic partners.
  • Established dual-source supply chains for raw materials used in self-manufactured commercial products.
  • Conducted 122 quality audits of suppliers; delivered capacity-building training to approximately 170 suppliers; deployed over 400 personnel to provide on-site quality supervision, guidance, and training at 10 key supplier sites.

Empowering Talent and Igniting Potential

A thriving talent ecosystem fuels our innovation. At Innovent, we view our employees as the foundation of long-term success and are deeply committed to cultivating a fair, inclusive, and empowering workplace. We offer diverse career development pathways and a multi-tiered professional development training system tailored to different career stages. Our comprehensive compensation and benefits framework is designed to strengthen employees’ sense of belonging, while enhancing our ability to attract, retain, and develop top talent. Committed to making Innovent a learning institution, we support employees in achieving both personal and professional growth.

  • Women represent 51% of total employees and hold 44.2% of management positions.
  • Key talent retention rate reached 96.8%.
  • Employee satisfaction rate exceeded 98%.
  • The “Innovent Beginning” Campus Recruitment Program offered over 2,100 job opportunities to new graduates from nearly 20 provinces.
  • All operational production facilities are 100% ISO 45001 occupational health and safety (OH&S) certified.

Safeguarding the Green Future with a Commitment to Sustainability

Green development underpins Innovent’s high-quality growth strategy. We are committed to eco-friendly practices that protect natural resources and ecosystems while actively contributing to global climate action. Through comprehensive climate risk assessments, we evaluate the potential operational impacts of climate change and implement measures to reduce our business activities’ climate impacts. By integrating green, low-carbon principles across all aspects of our production and operations, we continue to set clear targets that drive continuous improvement in our environmental performance and contribute to a more sustainable future.

  • 100% of operational production facilities are certified under the ISO 14001 Environmental Management System.
  • Successfully completed one internal and one external environmental management audit to ensure ongoing compliance and system integrity.
  • 29% reduction in energy consumption (per unit of production) compared to the previous year.
  • Reduced fresh water use by 22% (per unit of production) compared to the previous year.
  • Recycled a total of 51,100 tons of water, reflecting out commitment to resource conservation.
  • Innovent Shanghai Global R&D Center was awarded LEED Gold certification by the U.S. Green Building Council (USGBC).

Innovent remains firmly committed to sustainable development and global innovation. We will continue strategically consolidating our business momentum while pursuing breakthrough innovations in science. By harmonizing business success with long-term social value, Innovent is steadily progressing toward its vision of becoming a premier global biopharmaceutical company.

About Innovent

Innovent is a leading biopharmaceutical company founded in 2011 with the mission to empower patients worldwide with affordable, high-quality biopharmaceuticals. The company discovers, develops, manufactures and commercializes innovative medicines that target some of the most intractable diseases. Its pioneering therapies treat cancer, cardiovascular and metabolic, autoimmune and eye diseases. Innovent has launched 15 products in the market. It has 3 new drug applications under regulatory review, 4 assets in Phase III or pivotal clinical trials and 15 more molecules in early clinical stage. Innovent partners with over 30 global healthcare companies, including Eli Lilly, Sanofi, Incyte, Adimab, LG Chem and MD Anderson Cancer Center.

Guided by the motto, “Start with Integrity, Succeed through Action,” Innovent maintains the highest standard of industry practices and works collaboratively to advance the biopharmaceutical industry so that first-rate pharmaceutical drugs can become widely accessible. For more information, visit www.innoventbio.com, or follow Innovent on Facebook and LinkedIn.

Statement:

(1)Innovent does not recommend the use of any unapproved drug (s)/indication (s).

(2)Ramucirumab (Cyramza) and Selpercatinib (Retsevmo) and Pirtobrutinib (Jaypirca) were developed by Eli Lilly and Company.

Forward-looking statement

This news release may contain certain forward-looking statements that are, by their nature, subject to significant risks and uncertainties. The words “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, as they relate to Innovent, are intended to identify certain of such forward-looking statements. Innovent does not intend to update these forward-looking statements regularly.

These forward-looking statements are based on the existing beliefs, assumptions, expectations, estimates, projections and understandings of the management of Innovent with respect to future events at the time these statements are made. These statements are not a guarantee of future developments and are subject to risks, uncertainties and other factors, some of which are beyond Innovent’s control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in our business, Innovent’s competitive environment and political, economic, legal and social conditions.

Innovent, the Directors and the employees of Innovent assume (a) no obligation to correct or update the forward-looking statements contained in this site; and (b) no liability in the event that any of the forward-looking statements does not materialize or turn out to be incorrect.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/innovent-released-2024-esg-report-underscoring-commitment-to-sustainable-development-and-global-innovation-302458421.html

SOURCE Innovent Biologics

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.